Adenocarcinoma of pancreas (Disease Or Phenotype)

Omim:MTHU017773

Nci:C8294

Mondo:MONDO:6047

Medcin:MEDCIN:31626

Mdr:MDR:10052747

Id:076e1155-2fa3-5c47-a722-a3d993b619b8

Efo:EFO:1000044

Doid:DOID:4074

Chv:CHV:27380

Results found

Linked to

	Label	Description
	[1,4']Bipiperidinyl-1'-carboxylic acid (S)-4,11-diethyl-4-hydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-yl ester indication Adenocarcinoma of pancreas Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	mitomycin C indication Adenocarcinoma of pancreas Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Erlotinib indication Adenocarcinoma of pancreas Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

[1,4']Bipiperidinyl-1'-carboxylic acid (S)-4,11-diethyl-4-hydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-yl ester indication Adenocarcinoma of pancreas

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

mitomycin C indication Adenocarcinoma of pancreas

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Erlotinib indication Adenocarcinoma of pancreas

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025